Display options
Share it on

Autism Res Treat. 2012;2012:724072. doi: 10.1155/2012/724072. Epub 2012 Jul 16.

Identification of Four Novel Synonymous Substitutions in the X-Linked Genes Neuroligin 3 and Neuroligin 4X in Japanese Patients with Autistic Spectrum Disorder.

Autism research and treatment

Kumiko Yanagi, Tadashi Kaname, Keiko Wakui, Ohiko Hashimoto, Yoshimitsu Fukushima, Kenji Naritomi

Affiliations

  1. Department of Medical Genetics, Graduate School of Medicine, University of The Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan.

PMID: 22934180 PMCID: PMC3420546 DOI: 10.1155/2012/724072

Abstract

Mutations in the X-linked genes neuroligin 3 (NLGN3) and neuroligin 4X (NLGN4X) were first implicated in the pathogenesis of X-linked autism in Swedish families. However, reports of mutations in these genes in autism spectrum disorder (ASD) patients from various ethnic backgrounds present conflicting results regarding the etiology of ASD, possibly because of genetic heterogeneity and/or differences in their ethnic background. Additional mutation screening study on another ethnic background could help to clarify the relevance of the genes to ASD. We scanned the entire coding regions of NLGN3 and NLGN4X in 62 Japanese patients with ASD by polymerase chain reaction-high-resolution melting curve and direct sequencing analyses. Four synonymous substitutions, one in NLGN3 and three in NLGN4X, were identified in four of the 62 patients. These substitutions were not present in 278 control X-chromosomes from unrelated Japanese individuals and were not registered in the database of Single Nucleotide Polymorphisms build 132 or in the Japanese Single Nucleotide Polymorphisms database, indicating that they were novel and specific to ASD. Though further analysis is necessary to determine the physiological and clinical importance of such substitutions, the possibility of the relevance of both synonymous and nonsynonymous substitutions with the etiology of ASD should be considered.

References

  1. J Neurosci. 2009 Sep 2;29(35):10843-54 - PubMed
  2. Clin Chem. 2007 Dec;53(12):2211-4 - PubMed
  3. Science. 2007 Jan 26;315(5811):525-8 - PubMed
  4. Am J Hum Genet. 2010 Sep 10;87(3):316-24 - PubMed
  5. Mol Psychiatry. 2005 Apr;10(4):329-32 - PubMed
  6. J Med Genet. 2006 May;43(5):e21 - PubMed
  7. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1710-5 - PubMed
  8. Nat Methods. 2010 Aug;7(8):575-6 - PubMed
  9. Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):74-5 - PubMed
  10. Haemophilia. 2008 Jul;14(4):723-8 - PubMed
  11. Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):220-1 - PubMed
  12. Nature. 2008 Oct 16;455(7215):903-11 - PubMed
  13. Hum Mol Genet. 2004 Jul 15;13(14):1471-7 - PubMed
  14. Nat Genet. 2003 May;34(1):27-9 - PubMed
  15. Pharmacogenomics. 2007 Jun;8(6):527-32 - PubMed
  16. Eur J Hum Genet. 2005 Dec;13(12):1285-92 - PubMed
  17. Behav Brain Funct. 2011 May 14;7:13 - PubMed
  18. Genet Test Mol Biomarkers. 2009 Oct;13(5):611-5 - PubMed
  19. Am J Hum Genet. 2004 Mar;74(3):552-7 - PubMed
  20. J Neurosci Res. 2009 Jul;87(9):1953-9 - PubMed
  21. Am J Med Genet B Neuropsychiatr Genet. 2004 Aug 15;129B(1):82-4 - PubMed
  22. Science. 2007 Oct 5;318(5847):71-6 - PubMed
  23. Am J Med Genet B Neuropsychiatr Genet. 2004 Nov 15;131B(1):43-7 - PubMed
  24. Anal Biochem. 1997 Feb 15;245(2):154-60 - PubMed
  25. Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):535-7 - PubMed
  26. Eur J Hum Genet. 2008 May;16(5):614-8 - PubMed

Publication Types